Page results
-
This provides information about a treatment for uterine fibroids known as ‘transcervical ultrasound-guided radiofrequency ablation’. You may also hear it called by the Manufacturer’s name ‘Sonata®’ for short.
-
A new trial led by UCLH and UCL is looking at whether music therapy can help patients recover from severe brain injury.
-
This page provides information about the thermoregulatory sweat test (TST).
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
-
If you need an assessment by a midwife or doctor that is outside of your routine antenatal appointments you will be invited to attend the Maternal and Fetal Assessment Unit (MFAU).
-
Our new report shows the difference charitable funds can make to patients, staff and research at UCLH
-
Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.
-
Miss Nathalie Zaidman is a consultant spinal neurosurgeon specialising in complex spinal surgery.
-
This page explains what FACETS is and how it can help you.
-
To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.
File results
-
FOI/2024/0462 - Patient information leaflets and e-consent systems
-
FOI/2024/0198 - Nurse intake at Band 5
-
FOI/2024/0199 - Admission and discharge policies for violent assault injuries/ autism/ patient records/ inaccurate records
-
FOI/2024/0204 - Clinical insourcing for audiology and pathology
-
FOI/2024/0206 - Trusts budget allocated for cancer funding 2019/20-2023/24
-
FOI/2024/0207 - Physician Associates and prescribing/ ionising radiation
-
FOI/2024/0214 - Treatment for myeloproliferative neoplasms
-
FOI/2024/0219 - Incidence and treatment of colorectal cancer
-
FOI/2024/0221 - Inbound patient enquiries
-
FOI/2024/0223 - Treatment of cancer secondary care